Mass spectrometry analysis of urine and catheter of a patient with purple urinary bag syndrome

Clinica Chimica Acta

Volumn 378, Issue 1-2, 2007, Pages 216-218

  Bar Or, David ^a,b   Rael, Leonard T ^a,b   Bar Or, Raphael ^a,b   Craun, Michael L ^a   Statz, Jessica ^c   Garrett, Raymond E ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b DMI BioSciences Inc   (United States)

^c Swedish Family Medicine   (United States)

Author keywords

Indigo; Indoxyl sulfate; Mass spectrometry; Purple urinary bag syndrome (PUBS); Tryptophan metabolism; Urinary tract infection

Indexed keywords

INDICAN; LEVOFLOXACIN; LINEZOLID;

ACIDITY; AGED; ARTICLE; ASSAY; CASE REPORT; CATHETER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY COLLECTING TUBULE; KIDNEY DISEASE; MASS SPECTROMETRY; PRIORITY JOURNAL; PURPLE URINARY BAG SYNDROME; QUANTITATIVE ANALYSIS; URINALYSIS; URINE SEDIMENT;

AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INDICAN; INDOLES; MASS SPECTROMETRY; SYNDROME; TRYPTOPHAN; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 33846934715     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.11.015     Document Type: Article

References (9)

1. Wang I.K., Ho D.R., Chang H.Y., Lin C.L., and Chuang F.R. Purple urine bag syndrome in a hemodialysis patient. Intern Med 44 (2005) 859-861
2. Ribeiro J.P., Marcelino P., Marum S., Fernandes A.P., and Grilo A. Case report: purple urine bag syndrome. Crit Care 8 (2004) R137-R138
3. Vallejo-Manzur F., Mireles-Cabodevila E., and Varon J. Purple urine bag syndrome. Am J Emerg Med 23 (2005) 521-524
4. Dealler S.F., Hawkey P.M., and Millar M.R. Enzymatic degradation of urinary indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple urine bag syndrome. J Clin Microbiol 26 (1988) 2152-2156
5. Gelasco A.K., and Raymond J.R. Indoxyl sulfate induces complex redox alterations in mesangial cells. Am J Physiol Renal Physiol 290 (2006) F1551-F1558
6. Dou L., Bertrand E., Cerini C., et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65 (2004) 442-451
7. Brunet P., Dou L., Cerini C., and Berland Y. Protein-bound uremic retention solutes. Adv Renal Replace Ther 10 (2003) 310-320
8. Motojima M., Hosokawa A., Yamato H., Muraki T., and Yoshioka T. Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake. Br J Pharmacol 135 (2002) 555-563
9. Sakai T., Yamasaki K., Sako T., Kragh-Hansen U., Suenaga A., and Otagiri M. Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharm Res 18 (2001) 520-524